Related Experiment Video

Updated: Jul 18, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of

Xiang Chen1, Jing Lin, Takuro Kanekura

  • 1Department of Dermatology, XiangYa Hospital, Central South University, Changsha, Hunan, China. chenxck@yahoo.com

Cancer Research
|December 6, 2006
PubMed

Insights

Blocking CD147 in melanoma cells using small interfering RNA (siRNA) reduced tumor growth and metastasis. This approach suppressed cancer cell proliferation, invasion, and the formation of new blood vessels, offering a potential therapeutic strategy for malignant melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • CD147 is crucial for malignant melanoma cell invasion and metastasis.
  • It stimulates fibroblasts to produce matrix metalloproteinases and vascular endothelial growth factor.
  • Targeting CD147 presents a potential therapeutic avenue for melanoma.

Purpose of the Study:

  • To investigate the effect of blocking CD147 in human malignant melanoma cells (A375) using RNA interference.
  • To assess the impact of CD147 down-regulation on melanoma cell proliferation, invasion, and angiogenesis.
  • To evaluate the in vivo efficacy of CD147 blockade in xenograft and metastasis models.

Main Methods:

  • Development of a system to block CD147 in A375 cells via RNA interference.
  • Transfection of melanoma cells with small interfering RNA (siRNA) targeting human CD147.
  • Establishment of stable cell clones with significantly down-regulated CD147 expression.
  • In vitro assays for proliferation and invasion; assessment of vascular endothelial growth factor expression and endothelial cell migration.
  • In vivo studies using A375 subcutaneous xenograft and pulmonary metastasis nude mouse models.

Main Results:

  • Stable down-regulation of CD147 expression was achieved in A375 cells.
  • Reduced in vitro proliferation and invasion of A375 cells.
  • Decreased expression of vascular endothelial growth factor and reduced migration of vascular endothelial cells.
  • Suppressed subcutaneous tumor size and microvessel density in xenograft models.
  • Inhibited in vivo metastatic potential in pulmonary metastasis models.

Conclusions:

  • CD147 blockade using siRNA significantly inhibits malignant melanoma cell proliferation and invasion.
  • Down-regulation of CD147 suppresses tumor growth, angiogenesis, and metastasis in vivo.
  • Targeting CD147 represents a promising strategy for the treatment of malignant melanoma.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...